|
Volume
21 Number 11
30 November 2019
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
21, Year 2019 >
Number
11, 30 November
|
|
|
|
|
|
Huang
W, Sundquist J, Sundquist K, Ji J.
Mortality
patterns in long-term survivors of childhood or adolescent central
nervous system tumour in Sweden.
J
Neurooncol. 2019 Nov 1, 2019;145(3):541-549∟.
doi: 10.1007/s11060-019-03321-w∟.
PMID: 31677032∟.
Observational
study. ˍ
|
|
|
|
Ostrom
QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C,
Barnholtz-Sloan JS.
CBTRUS
Statistical Report: Primary Brain and Other Central Nervous System
Tumors Diagnosed in the United States in 2012-2016.
Neuro
Oncol. 2019 Nov 1, 2019;21(S5):1-100∟.
doi: 10.1093/neuonc/noz150∟.
PMID: 31675094∟.
Observational
study. ˍ
|
|
|
|
Phipps
K, Kirkman MA, Aquilina K, Gaze M, Michalski A, Wade A, Hayward R.
Childhood
medulloblastoma-a single institution's historical perspective on
survival and functional morbidity.
Childs
Nerv Syst. 2019 Nov 4, 2019;35(12):2327-2338∟.
doi: 10.1007/s00381-019-04402-x∟.
PMID: 31686139∟.
Observational
study. ˍ
|
|
|
|
Choi
SW, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Lee JI.
Fractionated
stereotactic radiosurgery for malignant gliomas: comparison with
single session stereotactic radiosurgery.
J
Neurooncol. 2019 Nov 8, 2019;145(3):571-579∟.
doi: 10.1007/s11060-019-03328-3∟.
PMID: 31705245∟.
Observational
study. ˍ
|
|
|
|
Alexandre
AM, Ciardi C.
Magnetic
Resonance Spectroscopy for Identification of Isocitrate
Dehydrogenase Mutation in Gliomas.
World
Neurosurg. 2019 Nov 11, 2019;134:193-195∟.
doi: 10.1016/j.wneu.2019.10.118∟.
PMID: 31669686∟.
Comment.
ˍ
Refers
to:
Di
Ieva A, et al.,Magnetic Resonance Spectroscopic Assessment of
Isocitrate Dehydrogenase Status in Gliomas: The New Frontiers of
Spectrobiopsy in Neurodiagnostics.
World Neurosurg. 2019 Sep
14, 2020;133:e421-e427∟.
doi: 10.1016/j.wneu.2019.09.040∟.
PMID: 31526886∟.
Observational
study.
ˍ
|
|
|
|
Ohno
M, Miyakita Y, Takahashi M, Igaki H, Matsushita Y, Ichimura K,
Narita Y.
Survival
benefits of hypofractionated radiotherapy combined with
temozolomide or temozolomide plus bevacizumab in elderly patients
with glioblastoma aged ≥ 75 years.
Radiat
Oncol. 2019 Nov 12, 2019;14(1):200∟.
doi: 10.1186/s13014-019-1389-7∟.
PMID: 31718669∟.
Observational
study. ˍ
|
|
|
|
Ferreira
LP, Pinheiro CF, Fernandes NA, Ferreira CN.
When
Depression Hides a Brain Tumor: A Case of Glioblastoma.
Prim
Care Companion CNS Disord. 2019 Nov 14, 2019;21(6):19l02455∟.
doi: 10.4088/PCC.19l02455∟.
PMID: 31730304∟.
Case
report. ˍ
|
|
|
*
|
Izzuddeen
Y, Gupta S, Haresh KP, Sharma D, Giridhar P, Rath GK.
Hypofractionated
radiotherapy with temozolomide in diffuse intrinsic pontine
gliomas: a randomized controlled trial.
J
Neurooncol. 2019 Nov 14, 2020;146(1):91-95∟.
doi: 10.1007/s11060-019-03340-7∟.
PMID: 31728883∟.
Interventional
study. ˍ
|
|
|
|
Muroi
A, Mizumoto M, Ishikawa E, Ihara S, Fukushima H, Tsurubuchi T,
Sakurai H, Matsumura A.
Proton
therapy for newly diagnosed pediatric diffuse intrinsic pontine
glioma.
Childs
Nerv Syst. 2019 Nov 14, 2020;36(3):507-512∟.
doi: 10.1007/s00381-019-04420-9∟.
PMID: 31728705∟.
Observational
study. ˍ
|
|
|
|
Schafer
ES, Rau RE, Berg SL, Liu X, Minard CG, Bishop AJR, Romero JC,
Hicks MJ, Nelson MD Jr, Voss S, Reid JM, Fox E, Weigel BJ, Blaney
SM.
Phase
1/2 trial of talazoparib in combination with temozolomide in
children and adolescents with refractory/recurrent solid tumors
including Ewing sarcoma: A Children's Oncology Group Phase 1
Consortium study (ADVL1411).
Pediatr
Blood Cancer. 2019 Nov 14, 2020;67(2):e28073∟.
doi: 10.1002/pbc.28073∟.
PMID: 31724813∟.
Interventional
study. ˍ
|
|
|
|
Simonetti
G, Sommariva A, Lusignani M, Anghileri E, Ricci CB, Eoli M,
Fittipaldo AV, Gaviani P, Moreschi C, Togni S, Tramacere I,
Silvani A.
Prospective
observational study on the complications and tolerability of a
peripherally inserted central catheter (PICC) in neuro-oncological
patients.
Support
Care Cancer. 2019 Nov 14, 2020;28(6):2789-2795∟.
doi: 10.1007/s00520-019-05128-x∟.
PMID: 31724074∟.
Observational
study. ˍ
|
|
|
|
Liu
H,
Sun Y, O'Brien JA, Franco-Barraza J, Qi X, Yuan H, Jin W, Zhang J,
Gu C, Zhao Z, Yu C, Feng S, Yu X.
Necroptotic
astrocytes contribute to maintaining stemness of disseminated
medulloblastoma through CCL2 secretion.
Neuro
Oncol. 2019 Nov 15, 2020;22(5):625-638∟.
doi: 10.1093/neuonc/noz214∟.
PMID: 31729527∟.
Laboratory
investigation.
ˍ
|
|
|
|
Cuccarini
V, Aquino D, Gioppo A, Anghileri E, Pellegatta S, Schettino C,
Mazzi F, Finocchiaro G, Bruzzone MG, Eoli M.
Advanced
MRI Assessment during Dendritic Cell Immunotherapy Added to
Standard Treatment Against Glioblastoma.
J
Clin Med. 2019 Nov 17, 2019;8(11):2007∟.
doi: 10.3390/jcm8112007∟.
PMID: 31744235∟.
Observational
study.
ˍ
|
|
|
|
John
F, Robinette NL, Amit-Yousif AJ, Bosnyák E, Barger GR, Shah
KD, Mittal S, Juhász C.
Multimodal
Imaging of Nonenhancing Glioblastoma Regions.
Mol
Imaging. 2019 Nov 18, 2019;18:1536012119885222∟.
doi: 10.1177/1536012119885222∟.
PMID: 31736437∟.
Observational
study. ˍ
|
|
|
|
Kessler
AF, Linsenmann T, Westermaier T, Wolber W, Weiland J, Monoranu CM,
Breun M, Hagemann C, Ernestus RI, Löhr M.
Complete
radiological response following subtotal resection in three
glioblastoma patients under treatment with Tumor Treating
Fields.
Oncol
Lett.
2019 Nov 19, 2020;19(1):557-561∟.
doi: 10.3892/ol.2019.11110∟.
PMID:
31897171∟.
Case
report. ˍ
|
|
|
|
Liu
WH, Lin JC, Chou YC, Li MH, Tsai JT.
CD44-associated
radioresistance of glioblastoma in irradiated brain areas with
optimal tumor coverage.
Cancer
Med. 2019 Nov 19, 2020;9(1):350-360∟.
doi: 10.1002/cam4.2714∟.PMID:
31746135∟.
Laboratory
investigation. ˍ
|
|
|
|
Matcovschii
V, Lisii D, Gudumac V, Dorosenco S.
Selective
interstitial doxorubicin for recurrent glioblastoma.
Clin
Case Rep.
2019 Nov 19, 2019;7(12):2520-2525∟.
doi: 10.1002/ccr3.2546∟.
PMID:
31893093∟.
Case report. ˍ
|
|
|
|
Shah
AH, Semonche A, Eichberg DG, Borowy V, Luther E, Sarkiss CA,
Morell A, Mahavadi AK, Ivan ME, Komotar RJ.
The
Role of Laser Interstitial Thermal Therapy in Surgical
Neuro-Oncology: Series of 100 Consecutive Patients.
Neurosurgery.
2019 Nov 19, 2020;87(2):266-275∟.
doi: 10.1093/neuros/nyz424∟.
PMID: 31742351∟.
Observational
study. ˍ
|
|
|
|
Barthel
FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E,
Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB,
Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, Beroukhim R, Bock
C, Brastianos PK, Brat DJ, Brodbelt AR, Bruns AF, Bulsara KR,
Chakrabarty A, Chakravarti A, Chuang JH, Claus EB, Cochran EJ,
Connelly J, Costello JF, Finocchiaro G, Fletcher MN, French PJ,
Gan HK, Gilbert MR, Gould PV, Grimmer MR, Iavarone A, Ismail A,
Jenkinson MD, Khasraw M, Kim H, Kouwenhoven MCM, LaViolette PS, Li
M, Lichter P, Ligon KL, Lowman AK, Malta TM, Mazor T, McDonald KL,
Molinaro AM, Nam DH, Nayyar N, Ng HK, Ngan CY, Niclou SP, Niers
JM, Noushmehr H, Noorbakhsh J, Ormond DR, Park CK, Poisson LM,
Rabadan R, Radlwimmer B, Rao G, Reifenberger G, Sa JK, Schuster M,
Shaw BL, Short SC, Smitt PAS, Sloan AE, Smits M, Suzuki H,
Tabatabai G, Van Meir EG, Watts C, Weller M, Wesseling P,
Westerman BA, Widhalm G, Woehrer A, Yung WKA, Zadeh G, Huse JT, De
Groot JF, Stead LF, Verhaak RGW; GLASS Consortium.
Longitudinal
molecular trajectories of diffuse glioma in adults.
Nature.
2019 Nov 20, 2019;576(7785):112-120∟.
doi: 10.1038/s41586-019-1775-1∟.
PMID: 31748746∟.
Laboratory
investigation. ˍ
|
|
|
|
Furtak
J, Mielczarek M, Szylberg M, Harat M.
Biomarker
concordance between molecular stereotactic biopsy and open
surgical specimens in gliomas.
Neurol
Neurochir Pol. 2019 Nov 20, 2019;53(6):435-441∟.
doi: 10.5603/PJNNS.a2019.0056∟.
PMID: 31746452∟.
Observational
study.
ˍ
|
|
|
|
van
den Bent M, Eoli M, Sepulveda JM, Smits M, Walenkamp A, Frenel JS,
Franceschi E, Clement PM, Chinot O, de Vos F, Whenham N, Sanghera
P, Weller M, Dubbink HJ, French P, Looman J, Dey J, Krause S,
Ansell P, Nuyens S, Spruyt M, Brilhante J, Coens C, Gorlia T,
Golfinopoulos V.
INTELLANCE
2/EORTC 1410 randomized phase II study of Depatux-M alone and with
temozolomide vs temozolomide or lomustine in recurrent
EGFRamplified glioblastoma.
Neuro
Oncol. 2019 Nov 20, 2020;22(5):684-693∟.
doi: 10.1093/neuonc/noz222∟.
PMID: 31747009∟.
Interventional
study. ˍ
|
|
|
|
Piña
Y, Fusco MJ, Macaulay RJ, Walko CM, Peguero E, Evernden BR,
Smalley KS, Forsyth P.
Using
personalized medicine in gliomas: a genomic approach to diagnosis
and overcoming treatment resistance in a case with pleomorphic
xanthoastrocytoma.
J
Neurol. 2019 Nov 21, 2020;267(3):783-790∟.
doi: 10.1007/s00415-019-09575-8∟.
PMID: 31748891∟.
Case
report. ˍ
|
|
|
|
Seystahl
K, Hentschel B, Loew S, Gramatzki D, Felsberg J, Herrlinger U,
Westphal M, Schackert G, Thon N, Tatagiba M, Pietsch T,
Reifenberger G, Löffler M, Wick W, Weller M; German Glioma
Network.
Bevacizumab
versus alkylating chemotherapy in recurrent glioblastoma.
J
Cancer Res Clin Oncol. 2019 Nov 21, 2020;146(3):659-670∟.
doi: 10.1007/s00432-019-03086-9∟.
PMID: 31754832∟.
Observational
study. ˍ
|
|
|
|
Zeiner
PS, Kinzig M, Divé I, Maurer GD, Filipski K, Harter PN,
Senft C, Bähr O, Hattingen E, Steinbach JP, Sörgel F,
Voss M, Steidl E, Ronellenfitsch MW.
Regorafenib
CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant
Glioma Patients.
J
Clin Med. 2019 Nov 21, 2019;8(12):2031∟.
doi: 10.3390/jcm8122031∟.
PMID: 31766326∟.
Observational
study. ˍ
|
|
|
|
Barresi
V, Eccher A, Simbolo M, Cappellini R, Ricciardi GK, Calabria F,
Cancedda M, Mazzarotto R, Bonetti B, Pinna G, Sala F, Ghimenton C,
Scarpa A.
Diffuse
gliomas in patients aged 55 years or over: A suggestion for
IDH mutation testing.
Neuropathology.
2019 Nov 22, 2020;40(1):68-74∟.
doi: 10.1111/neup.12608∟.
PMID: 31758617∟.
Observational
study. ˍ
|
|
|
|
Laghari
AA, Baig MZ, Bari E, Darbar A, Mushtaq N, Hani Abdullah UE, Khan
DA.
Pediatric
Brainstem Gliomas: An Institutional Experience.
Asian
J Neurosurg.
2019
Nov 25, 2019;14(4):1144-1150∟.
doi: 10.4103/ajns.AJNS_101_19∟.
PMID:
31903354∟.
Observational
study.
ˍ
|
|
|
|
Kahalley
LS, Peterson R, Ris MD, Janzen L, Okcu MF, Grosshans DR, Ramaswamy
V, Paulino AC, Hodgson D, Mahajan A, Tsang DS, Laperriere N,
Whitehead WE, Dauser RC, Taylor MD, Conklin HM, Chintagumpala M,
Bouffet E, Mabbott D.
Superior
Intellectual Outcomes After Proton Radiotherapy Compared With
Photon Radiotherapy for Pediatric Medulloblastoma.
J
Clin Oncol. 2019 Nov 27, 2020;38(5):454-461∟.
doi: 10.1200/JCO.19.01706∟.
PMID: 31774710∟.
Observational
study. ˍ
|
|
|
|
Lafay-Cousin
L, Bouffet E, Strother D, Rudneva V, Hawkins C, Eberhart C,
Horbinski C, Heier L, Souweidane M, Williams-Hughes C, Onar-Thomas
A, Billups CA, Fouladi M, Northcott P, Robinson G, Gajjar A.
Phase
II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children
Younger Than 4 Years of Age: A Report of the Children's Oncology
Group (ACNS1221).
J
Clin Oncol. 2019 Nov 27, 2020;38(3):223-231∟.
doi: 10.1200/JCO.19.00845∟.
PMID: 31774708∟.
Interventional
study. ˍ
|
|
|
|
Tinkle
CL, Simone B, Chiang J, et al.
Defining
Optimal Target Volumes of Conformal Radiation Therapy for Diffuse
Intrinsic Pontine Glioma.
Int
J Radiat Oncol Biol Phys. 2019 Nov 27, 2020;106(4):838-847∟.
doi:10.1016/j.ijrobp.2019.11.020∟.
PMID: 31785339∟.
Observational
study. ˍ
|
|
|
|
van
den Bent M, Azaro A, De Vos F, Sepulveda J, Yung WKA, Wen PY,
Lassman AB, Joerger M, Tabatabai G, Rodon J, Tiedt R, Zhao S,
Kirsilae T, Cheng Y, Vicente S, Balbin OA, Zhang H, Wick W.
A
Phase Ib/II, open-label, multicenter study of INC280 (capmatinib)
alone and in combination with buparlisib (BKM120) in adult
patients with recurrent glioblastoma.
J
Neurooncol. 2019 Nov 27, 2020;146(1):79-89∟.
doi: 10.1007/s11060-019-03337-2∟.
PMID: 31776899∟.
Interventional
study. ˍ
|
|
|
|
Hirono
S, Hasegawa Y, Sakaida T, Uchino Y, Hatano K, Iuchi T.
Feasibility
study of finalizing the extended adjuvant temozolomide based on
methionine positron emission tomography (Met-PET) findings in
patients with glioblastoma.
Sci
Rep. 2019 Nov 28, 2019;9(1):17794∟.
doi: 10.1038/s41598-019-54398-2∟.
PMID: 31780768∟.
Observational
study. ˍ
|
|
|
|
Uckun
FM, Qazi S, Hwang L, Trieu VN.
Recurrent
or Refractory High-Grade Gliomas Treated by Convection-Enhanced
Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc
Analysis with Long-Term Follow-Up.
Cancers
(Basel). 2019 Nov 28, 2019;11(12):1892∟.
doi:10.3390/cancers11121892∟.
PMID: 31795071∟.
Observational
study. ˍ
|
|
|
|
Hayashi
A, Ito E, Omura M, et al.
Hypofractionated
radiotherapy in children with diffuse intrinsic pontine
glioma.
Pediatr
Int. 2019 Nov 30, 2019;10.1111/ped.14070∟.
doi:10.1111/ped.14070∟.
PMID: 31785177∟.
Observational
study. ˍ
|
|
|
|
|
|
|
|
|
